arrow_back Back to App

REMEDY Act: Ending Drug Patent Extensions

This act aims to speed up the market entry of cheaper generic drugs. It limits pharmaceutical companies' ability to repeatedly extend patent protection for the same drug, potentially lowering drug prices and increasing accessibility for citizens.
Key points
Pharmaceutical companies will only be able to select one patent for protection against generic competition, shortening the wait for cheaper alternatives.
The changes aim to prevent practices that artificially prolong drug monopolies, potentially leading to lower prices and more choices for patients.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2620
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2025-07-31